Ubs Group Ag Virios Therapeutics, Inc. Transaction History
Ubs Group Ag
- $400 Billion
- Q2 2024
A detailed history of Ubs Group Ag transactions in Virios Therapeutics, Inc. stock. As of the latest transaction made, Ubs Group Ag holds 151,779 shares of VIRI stock, worth $673,898. This represents 0.0% of its overall portfolio holdings.
Number of Shares
151,779Holding current value
$673,898% of portfolio
0.0%Shares
12 transactions
Others Institutions Holding VIRI
# of Institutions
27Shares Held
978KCall Options Held
0Put Options Held
0-
Vanguard Group Inc Valley Forge, PA209KShares$927,4400.0% of portfolio
-
Geode Capital Management, LLC Boston, MA174KShares$774,6420.0% of portfolio
-
Susquehanna International Group, LLP Bala Cynwyd, PA66KShares$293,0000.0% of portfolio
-
Hrt Financial LP New York, NY57.5KShares$255,4950.0% of portfolio
-
State Street Corp Boston, MA52.8KShares$234,5560.0% of portfolio
About Virios Therapeutics, Inc.
- Ticker VIRI
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 18,330,400
- Market Cap $81.4M
- Description
- Virios Therapeutics, Inc., a development-stage biotechnology company, focuses on developing antiviral therapies to treat diseases associated with a viral triggered abnormal immune response. The company's lead development candidate is the IMC-1, a fixed dose combination of famciclovir and celecoxib to treat fibromyalgia. It is also developing IMC...